This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to analgesic agent
Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
253 |
4. Check minimum number of eventsNone |
253 |
5. Include endpointsNone |
253 |
6. Filter based on genotype QC (FinnGen only) |
235 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ASAINTOL
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z88
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to analgesic agent
based on the number of shared cases.
Similar with more cases:
- Personal history of allergy to drugs, medicaments and biological substances
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 235 | 159 | 76 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 52.32 | 50.80 | 55.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 244
- Matched controls
- 2440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J32.4
ICD-10 Finland
Chronic pansinusitis
334.6
310.2
147
11
J33.0
ICD-10 Finland
Polyp of nasal cavity
184.9
309.4
158
24
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
307.7
244
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
106.3
253.2
139
30
J33.8
ICD-10 Finland
Other polyp of sinus
127.1
244.1
128
21
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
49.4
207.1
143
68
J45.1
ICD-10 Finland
Nonallergic asthma
37.0
183.3
143
90
UDH02
NOMESCO Finland
Rhinopharyngoscopy
30.2
161.9
135
96
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
28.0
151.0
190
272
R03DC03
ATC
montelukast; oral
25.7
146.8
184
260
J45.0
ICD-10 Finland
Predominantly allergic asthma
23.6
145.5
147
147
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
39.6
144.3
97
40
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
20.9
126.9
125
117
TDM10
NOMESCO Finland
Puncture of maxillary antrum
26.6
123.6
98
60
J45.9
ICD-10 Finland
Asthma, unspecified
18.2
120.1
170
273
XQ800
NOMESCO Finland
Prick test
18.9
110.7
109
100
R03BB04
ATC
tiotropium bromide; inhalant
20.1
110.1
102
84
DHB20
NOMESCO Finland
Polypectomy of internal nose
248.2
105.9
102
7
R01AD05
ATC
budesonide; nasal
17.9
101.3
100
91
R01AD08
ATC
fluticasone; nasal
20.6
95.7
209
548
C01CA24
ATC
epinephrine; parenteral
15.3
93.4
103
111
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
55.5
84.4
49
11
ZXA10
NOMESCO Finland
Bilateral
10.4
75.8
126
228
J45
ICD-10 Finland
Asthma
11.6
75.3
101
140
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
16.3
73.7
71
60
H02AB07
ATC
prednisone; oral
10.4
70.3
104
162
R03BA02
ATC
budesonide; inhalant
9.3
69.9
137
295
H02AB04
ATC
methylprednisolone; systemic
9.1
63.8
108
195
R03AK06
ATC
salmeterol and fluticasone; inhalant
9.1
63.5
107
192
H02AB06
ATC
prednisolone; systemic
14.0
61.2
213
805
R03AK08
ATC
formoterol and beclometasone; inhalant
14.0
60.0
62
58
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
9.4
58.9
90
143
DPA30
NOMESCO Finland
Sphenotomy
93.6
58.5
63
9
D11AH05
ATC
dupilumab; topical
344.7
55.6
54
*
J33.9
ICD-10 Finland
Nasal polyp, unspecified
147.9
55.5
57
5
R03DA04
ATC
theophylline; systemic, rectal
19.5
54.3
45
28
395
Kela drug reimbursment
Dupilumab
328.5
53.4
52
*
J46
ICD-10 Finland
Status asthmaticus
20.9
49.1
39
22
M01AE01
ATC
ibuprofen; systemic, rectal
0.2
47.5
124
2126
R03AK07
ATC
formoterol and budesonide; inhalant
6.4
46.9
132
381
R03AC02
ATC
salbutamol; inhalant
15.6
43.3
227
1124
R03BA05
ATC
fluticasone; inhalant
6.1
43.2
115
312
R03AC12
ATC
salmeterol; inhalant
12.1
37.9
41
40
ZXD10
NOMESCO Finland
Scheduled procedure
5.4
37.2
155
597
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
12.0
36.1
39
38
J33
ICD-10 Finland
Nasal polyp
112.0
35.9
38
*
ZXE00
NOMESCO Finland
One hour or less
5.3
35.2
162
667
R03AC13
ATC
formoterol; inhalant
9.4
34.9
46
59
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
13.0
34.3
35
31
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.0
33.0
45
60
DHB50
NOMESCO Finland
Turbinoplasty
12.6
32.7
34
31
R01AD58
ATC
fluticasone, combinations; nasal
4.7
31.8
135
512
J45.8
ICD-10 Finland
Mixed asthma
13.0
31.6
32
28
Z2221
NOMESCO Finland
Medical doctor
4.6
31.4
130
483
R01AD09
ATC
mometasone; nasal
5.6
31.3
190
941
ZXE10
NOMESCO Finland
More than one and less than three hours
4.6
31.1
143
574
ZXC95
NOMESCO Finland
Use of surgical navigator
46.5
29.9
36
9
WX002
NOMESCO Finland
Sedation and analgesia
5.0
29.8
85
235
R96
ICPC
Asthma
6.4
29.8
58
114
R06AE09
ATC
levocetirizine; oral
5.0
29.6
86
241
R06AX27
ATC
desloratadine; oral
4.4
29.1
143
595
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.2
29.0
38
48
R03AK11
ATC
formoterol and fluticasone; inhalant
12.5
28.1
29
26
R01AD12
ATC
fluticasone furoate; nasal
4.3
28.1
148
643
WX408
NOMESCO Finland
General anesthesy, balanced
4.4
28.0
110
387
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
5.0
27.7
77
207
R03BA08
ATC
ciclesonide; inhalant
5.8
27.4
59
127
R03BA01
ATC
beclometasone; inhalant
4.9
26.2
73
196
R06AE07
ATC
cetirizine; oral
4.4
26.0
171
853
ZXD20
NOMESCO Finland
Day surgery
5.0
25.8
68
174
R03AC03
ATC
terbutaline; inhalant
4.8
25.7
74
204
R01AD01
ATC
beclometasone; nasal
4.3
23.3
79
245
WX402
NOMESCO Finland
General anaesthesia
4.0
23.2
94
331
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
32.7
22.4
29
10
J01AA02
ATC
doxycycline; systemic
9.3
22.0
229
1518
T78.4
ICD-10 Finland
Allergy, unspecified
7.1
21.6
35
56
4222
FHL
Endonasal etmoidectomy
66.2
21.3
24
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
9.6
21.0
26
30
Z3231
NOMESCO Finland
Registered nurse
3.4
19.5
107
452
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.4
19.1
114
506
R03DX09
ATC
mepolizumab; parenteral
+∞
19.0
18
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.9
18.6
46
110
Z51.6
ICD-10 Finland
Desensitization to allergens
20.6
17.8
26
14
R06AX13
ATC
loratadine; oral
3.6
17.7
77
278
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
45.7
17.6
21
5
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.8
17.3
25
35
3028
Kela drug reimbursment
Mepolizumab
181.9
16.7
17
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
16.6
136
710
DHA10
NOMESCO Finland
Biopsy of cavity of nose
32.6
16.4
21
7
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
51.2
16.3
19
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.3
16.1
178
1092
J01FA09
ATC
clarithromycin; systemic
3.0
16.0
117
571
J01FA06
ATC
roxithromycin; oral
3.0
15.8
128
659
J31.0
ICD-10 Finland
Chronic rhinitis
4.4
15.8
45
120
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
40.9
15.6
19
5
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
21.8
15.4
22
11
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.8
15.3
25
40
D72.1
ICD-10 Finland
Eosinophilia
60.6
15.0
17
*
J32.8
ICD-10 Finland
Other chronic sinusitis
38.6
14.7
18
5
R06AX22
ATC
ebastine; oral
3.2
14.6
75
297
J30.3
ICD-10 Finland
Other allergic rhinitis
5.9
14.4
27
50
J01MA14
ATC
moxifloxacin; systemic
4.3
14.2
41
110
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.9
13.9
26
48
R06AX26
ATC
fexofenadine; oral
4.2
13.3
39
106
R01BA52
ATC
pseudoephedrine, combinations; oral
2.8
13.2
101
494
Z01.7
ICD-10 Finland
Laboratory examination
3.1
13.1
70
282
XQ820
NOMESCO Finland
Exposure to medicinal substance
53.0
13.0
15
*
ZX112
NOMESCO Finland
Subcutaneous
12.0
12.8
23
21
297, ,
Kela drug reimbursment
+∞
12.6
12
*
R02
ICPC
Shortness of breath/dyspnoea
3.5
12.6
51
173
N02AX02
ATC
tramadol; systemic, rectal
2.6
12.5
127
711
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.3
12.0
21
36
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.4
11.9
32
81
J01FA10
ATC
azithromycin; systemic
2.8
11.6
181
1232
J33.1
ICD-10 Finland
Polypoid sinus degeneration
125.7
11.5
12
*
S01GX01
ATC
cromoglicic acid; ophthalmic
2.7
11.5
79
362
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
11.4
136
811
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
13.6
11.3
19
15
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
11.2
75
338
UDC00
NOMESCO Finland
Ear microscopy
4.4
11.1
30
76
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
29.5
10.8
14
5
L50.9
ICD-10 Finland
Urticaria, unspecified
4.7
10.8
26
60
R4110
NOMESCO Finland
Physiotherapy
2.6
10.7
89
445
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.3
10.7
45
156
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
10.6
140
865
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.5
10.5
21
24
J01DC02
ATC
cefuroxime; systemic
4.6
10.4
26
62
R03DC01
ATC
zafirlukast; oral
12.0
10.2
18
16
A07AA02
ATC
nystatin; oral
5.2
10.2
22
46
J01DA06
ATC
[U] cefuroxime
3.0
10.2
53
208
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
41.9
10.1
12
*
H66.9
ICD-10 Finland
Otitis media, unspecified
3.6
10.1
36
112
4224
FHL
Endonasal anthrostomy
17.6
10.0
15
9
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
+∞
9.4
9
*
R03DX10
ATC
benralizumab; systemic
+∞
9.4
9
*
251, ,
Kela drug reimbursment
+∞
9.4
9
*
3027
Kela drug reimbursment
Benralizumab
+∞
9.4
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
9.3
66
304
DJD20
NOMESCO Finland
Plastic repair of septum of nose
5.1
9.2
20
42
Z3226
NOMESCO Finland
Physiotherapist
2.7
9.2
60
265
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
19.5
9.0
13
7
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
9.2
9.0
18
21
J34.2
ICD-10 Finland
Deviated nasal septum
4.0
8.9
26
70
J02AC02
ATC
itraconazole; systemic
2.6
8.9
60
269
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
9.0
8.5
17
20
R01AD11
ATC
triamcinolone; nasal
3.3
8.4
34
114
UDM02
NOMESCO Finland
Sinoscopy
8.0
8.3
18
24
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.2
75
386
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.3
8.2
169
1210
4239
FHL
Other measure in this category
34.6
8.1
10
*
R03BB01
ATC
ipratropium bromide; inhalant
7.7
8.1
18
25
R01BA01
ATC
phenylpropanolamine; oral
4.2
8.1
22
56
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.2
8.1
93
527
J01CA04
ATC
amoxicillin; systemic
3.6
8.0
223
1825
J01FA15
ATC
telithromycin; oral
3.1
8.0
37
135
J01DB01
ATC
cefalexin; oral
3.3
7.8
220
1794
R03BB07
ATC
umeclidinium bromide; inhalant
19.1
7.7
11
6
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.6
7.5
25
74
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
82.5
7.5
8
*
A02BC05
ATC
esomeprazole; systemic
2.1
7.3
108
669
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
6.4
7.2
18
30
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.7
7.1
44
187
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.9
7.1
36
138
DFF00
NOMESCO Finland
Pure tone audiometry
3.1
7.0
31
110
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.3
7.0
27
88
49300
ICD-8 Finland
Asthma, bronchiale
8.7
6.9
14
17
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.7
6.9
14
17
H65.2
ICD-10 Finland
Chronic serous otitis media
9.7
6.9
13
14
DPA20
NOMESCO Finland
Trephine of frontal sinus
41.2
6.8
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
6.8
65
338
R08
ICPC
Nose symptom/complaint other
4.2
6.7
18
45
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
6.7
60
303
XG405
NOMESCO Finland
Education on PEF monitoring
12.7
6.6
11
9
J01.1
ICD-10 Finland
Acute frontal sinusitis
6.5
6.6
16
26
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
6.5
6.6
16
26
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
6.4
105
667
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
+∞
6.3
6
*
R03AC19
ATC
olodaterol
+∞
6.3
6
*
D22
ICD-10 Finland
Melanocytic naevi
3.3
6.2
24
78
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
8.0
6.2
13
17
R01AD59
ATC
mometasone, combinations; nasal
2.8
6.1
32
125
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.5
6.0
21
64
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
6.0
92
569
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
125
168
14.21
97.83
2.7
1.4
—
—
—
0
0
79
54
21.16
93.08
1.6
1.0
1.89
6.88
u/ml
1.02
72
30
84
66
18.88
91.97
1.6
1.2
0.41
2.45
u/ml
1.24
78
39
76
51
21.19
90.23
1.6
1.0
0.44
0.77
u/ml
0.46
69
25
51
17
37.66
79.24
1.5
1.1
0.41
0.07
u/ml
—
35
10
227
1183
14.19
39.17
8.0
7.3
0.38
0.18
e9/l
17.70
192
1039
226
1281
11.36
32.32
8.7
10.4
4.12
3.98
e9/l
0.49
190
1108
231
1883
5.26
9.50
20.1
16.1
13.38
13.38
%
0.02
231
1869
16
15
11.32
8.93
6.8
2.7
—
—
—
0
0
11
5
22.93
8.09
1.4
1.0
94.09
91.60
%
—
11
5
17
28
6.44
6.91
1.1
1.3
—
—
—
0
0
92
562
2.02
6.27
3.1
2.7
0.13
0.33
e6/l
1.07
55
396
45
206
2.45
6.24
2.2
2.4
38.76
29.58
u/l
0.33
33
166
92
579
1.95
5.65
1.7
1.6
—
—
—
0
0
79
486
1.93
5.11
1.7
1.7
1.64
1.06
mg/l
0.22
62
375
14
31
4.73
4.63
1.4
1.2
—
—
—
0
0
14
31
4.73
4.63
1.4
1.2
—
—
—
0
0
18
60
3.16
4.50
1.0
1.2
—
—
—
0
0
18
61
3.11
4.38
1.0
1.1
—
—
—
0
0
23
90
2.72
4.36
2.5
1.7
—
—
—
0
0
55
317
1.95
4.23
2.3
2.6
2.59
2.75
e6/l
0.04
17
133
15
49
3.20
3.88
1.4
1.3
—
—
—
0
0
6
5
12.25
3.78
3.0
12.0
—
—
—
0
0
23
100
2.44
3.55
1.8
1.5
—
—
—
0
0
8
241
0.31
3.55
3.3
4.4
33.50
31.88
%
—
8
162
33
168
2.12
3.55
3.9
3.0
—
—
—
0
0
8
13
6.32
3.53
1.1
2.2
—
—
—
0
0
20
85
2.47
3.25
1.5
1.7
—
—
—
0
0
78
539
1.66
3.20
2.0
2.6
315.21
326.06
umol/l
0.46
68
489
214
1907
1.99
3.19
19.4
16.9
330.69
333.12
g/l
3.30
214
1900
234
2165
2.97
3.11
15.4
12.8
23.04
21.30
mg/l
0.31
203
1709
227
2072
2.37
3.10
13.5
11.9
91.53
89.15
ml/min/173m2
1.34
213
1889
13
45
3.00
3.07
1.3
2.7
—
—
—
0
0
11
31
3.67
3.03
7.9
2.6
5.26
5.17
kpa
0.17
11
31
55
352
1.73
2.98
2.3
2.5
0.76
0.75
e6/l
0.01
17
167
54
347
1.71
2.88
3.5
3.5
14.61
343.62
ng/l
1.71
31
234
14
56
2.59
2.58
1.5
1.5
—
—
—
0
0
8
21
3.90
2.48
1.0
1.3
—
—
—
0
0
244
2376
+∞
2.46
23.8
20.5
138.03
136.72
g/l
1.01
244
2357
187
1642
1.59
2.45
4.1
3.6
—
—
—
0
0
41
255
1.73
2.45
1.6
2.6
4.23
7.38
umol/l
1.28
34
219
244
2374
+∞
2.45
23.6
20.3
90.57
90.56
fl
0.01
244
2357
244
2374
+∞
2.45
23.8
20.7
41.77
40.79
%
4.76
244
2354
11
38
2.98
2.45
1.5
1.1
—
—
—
0
0
119
958
1.47
2.32
2.3
2.6
74.36
74.43
nmol/l
0.01
108
875
8
23
3.56
2.29
1.1
1.3
—
—
—
0
0
8
23
3.56
2.29
1.1
1.3
—
—
—
0
0
35
213
1.75
2.25
1.7
1.8
—
—
—
0
0
21
109
2.01
2.18
5.9
8.6
25.62
25.07
mmol/l
0.33
21
109
6
14
4.36
2.16
1.2
3.6
227.67
632.00
u/ml
—
6
14
34
208
1.74
2.15
1.8
1.8
—
—
—
0
0
186
1650
1.54
2.14
2.7
3.2
34.37
42.55
u/l
1.14
178
1584
105
836
1.45
2.12
2.8
4.6
38.18
36.98
g/l
2.28
96
800
63
453
1.53
2.10
1.9
1.5
—
—
—
0
0
52
360
1.56
2.05
2.5
2.3
2.41
2.43
mmol/l
0.77
44
323
8
26
3.15
2.03
1.0
1.2
—
—
—
0
0
17
85
2.07
1.95
1.3
1.3
—
—
—
0
0
8
28
2.92
1.88
1.1
1.3
—
—
—
0
0
9
35
2.63
1.82
1.0
1.3
—
—
—
0
0
7
23
3.10
1.81
1.1
1.3
—
—
—
0
0
17
88
2.00
1.80
2.2
1.6
11.70
6.94
u/ml
—
5
20
102
829
1.40
1.76
3.4
6.1
1.22
1.21
mmol/l
0.14
97
768
7
24
2.97
1.73
1.0
1.2
—
—
—
0
0
96
775
1.39
1.72
2.1
3.2
24.32
30.35
u/l
3.38
88
734
28
174
1.69
1.70
1.4
1.3
16.17
21.81
iu/l
0.63
19
150
135
1161
1.36
1.60
2.7
3.4
0.00
0.00
estimate
0.50
27
241
128
1095
1.36
1.56
4.2
6.4
9.74
10.54
umol/l
0.93
120
1048
236
2273
2.17
1.54
15.9
15.9
70.00
72.69
umol/l
1.92
236
2243
0
43
0.00
1.54
0.0
1.1
—
12.50
—
0
6
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
109
915
1.35
1.48
3.4
6.9
1.22
1.21
mmol/l
1.17
89
805
78
622
1.37
1.47
1.4
1.3
0.72
1.83
u/ml
1.24
13
185
45
604
0.69
1.47
4.8
4.1
3.20
11.78
mg/mmol
2.79
27
394
23
142
1.68
1.44
1.0
1.0
—
—
—
0
0
188
1719
1.41
1.44
4.1
4.5
14.14
14.51
pmol/l
1.43
173
1606
135
1174
1.34
1.43
2.7
3.4
53.82
0.00
estimate
0.49
28
240
22
135
1.69
1.41
1.1
1.4
—
—
—
0
0
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
9
43
2.13
1.31
1.3
1.5
—
—
—
0
0
135
1183
1.32
1.31
2.8
3.4
0.00
0.03
estimate
0.80
26
230
18
108
1.72
1.26
1.9
3.3
24.08
24.35
mmol/l
0.15
18
108
6
25
2.43
1.25
1.0
1.2
—
—
—
0
0
6
25
2.43
1.25
1.7
1.4
—
—
—
0
0
6
26
2.34
1.19
1.5
1.2
—
—
—
0
0
13
219
0.57
1.16
5.9
5.8
—
—
—
0
0
36
262
1.44
1.14
2.1
2.1
—
—
—
0
0
17
104
1.68
1.12
1.6
1.5
—
—
—
0
0
174
1598
1.31
1.10
6.6
8.1
69.30
75.84
u/l
2.60
168
1507
10
52
1.96
1.07
1.3
1.5
—
—
—
0
0
17
106
1.65
1.06
1.6
1.5
0.94
0.98
ratio
0.21
11
62
17
106
1.65
1.06
1.6
1.5
1.00
1.16
ratio
0.51
11
62
17
106
1.65
1.06
1.6
1.5
1.04
1.05
ratio
0.02
11
62
5
108
0.45
1.03
1.0
1.4
—
—
—
0
0
41
528
0.73
1.03
1.9
3.3
1.02
1.02
kg/l
0.25
21
333
39
295
1.38
1.01
2.1
1.9
—
—
—
0
0
30
218
1.43
0.97
1.8
2.0
—
—
—
0
0
82
698
1.26
0.93
3.3
3.2
2.35
2.36
mmol/l
0.12
74
645
8
44
1.85
0.86
1.1
1.1
—
—
—
0
0
9
148
0.59
0.82
1.2
2.3
16.67
48.92
u/ml
—
9
143
5
96
0.51
0.80
1.4
1.7
—
—
—
0
0
212
2029
1.34
0.80
4.0
4.5
5.60
5.79
mmol/l
1.35
197
1902
0
24
0.00
0.79
0.0
4.0
—
66.15
—
0
24
37
290
1.33
0.78
3.5
2.8
0.49
0.75
ug/l
2.38
19
160
6
34
1.78
0.77
1.5
1.8
—
—
—
0
0
5
24
2.11
0.75
1.0
1.3
—
—
—
0
0
5
24
2.11
0.75
1.6
1.4
—
—
—
0
0
210
2015
1.30
0.70
5.4
5.4
1.65
1.84
mu/l
2.25
201
1893
127
1160
1.20
0.70
3.2
3.1
89.22
89.49
ug/l
0.00
118
1099
19
256
0.72
0.65
2.8
5.6
1.10
1.04
mmol/l
0.66
19
236
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
31
249
1.28
0.57
1.7
1.5
1019.74
1196.90
nmol/l
0.40
19
189
190
1977
0.82
0.57
5.0
5.4
37.64
38.19
mmol/mol
0.40
180
1887
6
38
1.59
0.54
2.0
2.2
6.57
8.09
pmol/l
—
6
38
54
466
1.20
0.54
1.5
1.4
11.72
27.10
iu/ml
2.85
14
145
9
63
1.44
0.53
1.1
1.3
—
—
—
0
0
50
431
1.20
0.51
1.3
1.3
4.84
8.86
u/ml
0.50
16
176
92
836
1.16
0.50
2.0
1.9
91.87
96.61
pmol/l
0.47
50
419
12
84
1.45
0.50
1.6
1.4
—
—
—
0
0
103
946
1.15
0.49
1.8
1.9
1.35
1.40
mmol/l
0.29
91
819
29
350
0.81
0.47
1.7
1.6
466.50
37621033.67
pmol/l
0.50
20
311
5
83
0.59
0.46
1.4
1.7
—
—
—
0
0
57
641
0.86
0.44
2.9
3.4
0.00
0.01
estimate
0.80
28
231
0
15
0.00
0.41
0.0
2.0
—
17.76
—
0
15
0
16
0.00
0.41
0.0
1.1
—
1.17
—
0
7
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.48
0.40
1.4
1.6
—
—
—
0
0
96
1034
0.88
0.40
2.2
2.6
—
—
estimate
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
53
470
1.16
0.40
2.0
2.9
233.71
816.87
ng/l
5.87
41
381
16
124
1.31
0.40
1.3
1.3
315.97
275.58
miu/ml
—
6
56
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
10
135
0.73
0.37
1.3
1.5
—
—
—
0
0
11
81
1.37
0.37
1.3
1.3
—
—
—
0
0
74
677
1.13
0.36
2.5
2.7
0.00
0.01
estimate
0.74
25
201
6
43
1.41
0.35
4.7
3.6
14.50
21.85
u/ml
—
6
43
7
96
0.72
0.31
1.1
1.9
—
—
—
0
0
17
139
1.24
0.30
1.4
1.5
—
—
—
0
0
7
57
1.23
0.29
1.6
1.6
—
—
—
0
0
14
170
0.81
0.26
2.2
2.4
84.25
72.73
ml/min/173m2
—
8
77
95
902
1.09
0.23
2.5
3.2
0.00
0.03
estimate
1.15
24
204
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
1.58
—
0
12
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
1893.00
—
0
13
0
13
0.00
0.21
0.0
8.8
—
34.20
—
0
5
7
62
1.13
0.17
4.1
3.4
10.43
1129.04
u/ml
—
7
52
212
2147
0.90
0.16
4.0
4.6
1.58
1.48
mmol/l
2.48
200
2041
219
2165
1.11
0.15
4.6
5.2
2.88
2.83
mmol/l
0.39
208
2057
213
2155
0.91
0.15
4.1
4.7
4.88
4.76
mmol/l
1.11
202
2058
39
365
1.08
0.13
3.7
4.1
19.00
21.54
%
—
9
149
68
655
1.05
0.10
2.0
2.4
49.24
63.28
u/l
1.32
59
617
5
45
1.11
0.10
1.4
1.6
—
—
—
0
0
117
1196
0.96
0.10
3.6
4.4
6.11
6.42
mmol/l
1.28
111
1115
27
253
1.08
0.09
1.9
1.7
3.63
3.55
mmol/l
0.13
19
183
47
453
1.05
0.07
2.2
2.2
—
—
—
0
0
18
168
1.08
0.06
2.6
2.5
11.24
20.73
au/ml
—
5
16
43
415
1.04
0.06
2.1
2.1
—
—
—
0
0
23
242
0.95
0.05
3.3
6.8
104.65
104.07
mmol/l
0.22
23
242
72
706
1.03
0.04
2.6
3.1
14.36
42.11
ng/l
2.37
33
415
34
330
1.04
0.03
2.1
1.9
3.47
3.49
ratio
0.04
25
261
12
128
0.93
0.02
2.1
1.5
0.17
0.33
mg/l
—
6
51
205
2043
1.02
0.01
3.3
3.9
1.17
1.29
mmol/l
1.56
192
1929
16
154
1.04
0.00
2.5
2.1
191.30
8946.66
u/l
—
5
65
11
111
0.99
0.00
1.0
1.1
1.59
1.56
g/l
0.12
11
111
10
103
0.97
0.00
1.3
2.5
0.51
0.58
%
—
10
103
11
113
0.97
0.00
1.0
1.1
1.00
0.89
g/l
1.02
11
113
10
104
0.96
0.00
1.3
2.5
0.92
1.34
%
—
10
104
18
184
0.98
0.00
4.6
8.6
1.31
0.86
mmol/l
0.22
13
154
52
515
1.01
0.00
1.7
2.1
—
—
—
0
0
6
64
0.94
0.00
1.0
1.4
—
—
—
0
0
7
69
1.01
0.00
1.1
1.6
—
0.01
—
0
9
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
4.44
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
59.42
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
45.19
—
0
7
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
6
59
1.02
-0.00
1.7
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
57.22
—
0
5
0
5
0.00
-0.00
0.0
2.8
—
10.78
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT – Personal history of allergy to analgesic agent
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).